6505--Cefuroxime Tablets (VA-26-00005794) 36E79725Q0006
Summary
AI-generated · Aug 24, 2025A national, mandatory contract is being explored to supply Cefuroxime Axetil Tablets for federal health-care programs, with the product lineup to be awarded in aggregate across all strengths and bottle sizes for the base year and up to four option years. The market research seeks to determine if firms can meet the government's minimum requirements and to gauge interest in submitting a formal solicitation response.
Respondents must provide: a separate 11-digit NDC for each proposed product (with the first five digits identifying the labeler), and ensure the contractor’s label is the only label on the product; a letter of commitment from the manufacturer if you are not the manufacturer; confirmation of a Pharmaceutical Prime Vendor (PPV) agreement or the ability to execute one in time to support distribution; company size under NAICS 325412 (Large or Small), and, if small, whether at least 50% of the product is manufactured in-house; designation of whether the end product is U.S.-made or from a Trade Agreements Act country; ability to meet the specified product configurations (Cefuroxime Axetil 250 mg and 500 mg tablets in 20- and 60-count bottles) and associated estimated annual usage; indication of willingness to respond to a solicitation, and ability to begin supplying within 60 days of award; and, if not interested, a stated reason. Also requested are the base year length and the number of optional years (not to exceed four).
MARKET RESEARCH QUESTIONNAIRE Cefuroxime Axetil Tablets Company Name: _________________________ I am conducting market research for the procurement of Cefuroxime Axetil Tablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following: 1. Is your Company able to meet the following minimum requirements: National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________ If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________ Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________ Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________ d. Under NAICS code 325412, is your company size (check one): Large Business ______ Small Business ______ e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________ f. Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________ g. Can your company meet the following product, bottle size and usage: ITEM DESCRIPTION PKG SIZE (Tablets per Bottle) TOTAL EST ANNUAL USAGE (Bottles) 1 Cefuroxime Axetil 250mg Tablet 20 2,159 2 Cefuroxime Axetil 250mg Tablet 60 4,394 3 Cefuroxime Axetil 500mg Tablet 20 2,179 4 Cefuroxime Axetil 500mg Tablet 60 7,241 2 . Is your Company interested in submitting a response to a solicitation?________ 3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________ 4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date? ______________________________________________________________________ 5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements. ______________________________________________________________________ If you could provide your responses by August 13 , 2025, it would be greatly appreciated. Please contact me if you have any questions.
From Sources Sought posted on Jul 30, 2025Notice history
1-
Sources Sought LATEST Posted Jul 30, 2025
Details
Award Information
Contacts
Contract Specialist
Phone